MRD & Disease Monitoring Archives

September 17, 2020

Dr. Susan Leclair on the Mathematics of MRD Testing and More

“There are three kinds of lies: lies, damned lies, and statistics.” I am certain many readers will be tempted to shy away from reading about how the mathematics of lab testing works, but if you stick with it, Dr. Susan Leclair’s two articles that follow will give you the

September 17, 2020

Minimal Residual Disease Assessment in CLL: Ready for Use in Clinical Routine?

The methodologies for testing MRD are evolving and finding less than 1 in 10,000 cells by flow cytometry is today’s standard definition for undetectable minimal or measurable residual disease (uMRD). There is good reason to believe that the deeper levels achievable with next generation gene sequencing (NGS), capable of

September 4, 2020

MRD Glossary

The CLL Society worked with a broad coalition of other stakeholders in the MRD TESTING COLLABORATIVE to produce a glossary of terms for those new to MRD (minimal or measurable residual disease). The COLLABORATIVE offers several patient friendly MRD related resources.

February 10, 2020

Bone Marrow Results: What does less that one in a million mean?

Bone Marrow Results: What does less that one in a million mean? Dr. Brian Koffman explains both FLOW cytometry testing, which can find as few as one in 10,000 cancer cells, and CLONOSEQ testing, which can find one cancer cell in one million.

MRD & Disease Monitoring

Dr. Susan Leclair on the Mathematics of MRD Testing and More

Minimal Residual Disease Assessment in CLL: Ready for Use in Clinical Routine?

MRD Glossary

Bone Marrow Results: What does less that one in a million mean?

CLL SOCIETY FAST FIND

QUICK LINKS

ABOUT US

CONTACT